XPHYTO THERAPEUTIC
XPhyto Therapeutics Corp. is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. The Company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets.
XPHYTO THERAPEUTIC
Social Links:
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.xphyto.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Euro Pound Sterling Japanese Yen
Similar Organizations
Affini-T Therapeutics
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-07-20 | 3A Composites | 3A Composites acquired by Xphyto Therapeutic | 3.9 M EUR |
Official Site Inspections
http://www.xphyto.com Semrush global rank: 6.4 M Semrush visits lastest month: 1.05 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Xphyto Therapeutic"
XPhyto Completes Corporate Rebranding and Launches New …
Mar 4, 2021 “The Company is excited to introduce a fresh look at such a pivotal point in our business growth,” said Hugh Rogers, CEO & Director of XPhyto. “With all technical …See details»
XPhyto Completes Corporate Rebranding and Launches New …
Mar 4, 2021 XPhyto Therapeutics Corp. Hugh Rogers, CEO and Director. Investor Inquiries: Mr. Knox Henderson T: 604-551-2360 E: [email protected] Media Inquiries: MC Services AG Julia …See details»
XPhyto Announces Name Change to BioNxt Solutions Inc. - Yahoo …
Nov 10, 2022 About BioNxt Solutions Inc. BioNxt Solutions Inc. is a bioscience accelerator focused on next-generation drug formulations and delivery systems, diagnostic screening …See details»
BioNxt Solutions - Next-gen drug delivery
Dec 19, 2024 At BioNxt Solutions, we are pioneering next-generation drug delivery technologies to address critical needs in neurodegenerative and autoimmune diseases.See details»
BioNxt Solutions - Crunchbase Company Profile & Funding
Organization. BioNxt Solutions . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Also Known As Xphyto Therapeutic; …See details»
XPhyto Announces Name Change to BioNxt Solutions Inc.
Nov 10, 2022 VANCOUVER, BC / ACCESSWIRE / November 10, 2022 / XPhyto Therapeutics Corp. ("XPhyto" or the "Company") (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) is pleased to …See details»
XPhyto Completes Corporate Rebranding and Launches New …
Mar 4, 2021 XPhyto Therapeutics Corp. is a bioscience accelerator... XPhyto Therapeutics Corp., is pleased to announce that the Company has completed a corporate rebranding and …See details»
XPhyto Completes Corporate Rebranding and Launches New …
Mar 4, 2021 XPhyto Therapeutics Corp., is pleased to announce that the Company has completed a corporate rebranding and launched a new website which can be viewed at …See details»
XPhyto Completes Corporate Rebranding and Launches New …
Mar 4, 2021 XPhyto Therapeutics Corp. Hugh Rogers, CEO and Director Investor Inquiries: Mr. Knox Henderson T: 604-551-2360 E: [email protected] Media Inquiries: MC Services AG Julia …See details»
XPhyto Completes Corporate Rebranding and Launches New …
May 31, 2024 VANCOUVER, BC / ACCESSWIRE / March 4, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ('XPhyto' or the 'Company'), is pleased to announce …See details»
XPhyto Reports on its Three Primary Business Divisions - Bionxt
Feb 8, 2022 About XPhyto Therapeutics Corp. XPhyto Therapeutics Corp. is a diversified bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active …See details»
XPhyto Reports Development Update for its Drug Delivery Business
Oct 12, 2021 VANCOUVER, BC and BIBERACH, GERMANY / ACCESSWIRE / October 12, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the …See details»
XPhyto Therapeutics - XPHY.F - Stock Price & News | The Motley …
XPhyto Therapeutics Company Info. BioNxt Solutions, Inc. engages in the business of producing, extracting, and selling medical cannabis. It focuses on the strategic assets and investments in …See details»
XPhyto: Taking biosensors to the next level - Health Europa
Feb 18, 2022 The acquisition of 3a also enables XPhyto to integrate 3a’s biosensor technology with its existing proprietary platform of oral, thin-film delivery strips. Originally developed and …See details»
XPhyto Announces Managing Director Appointment, Financing …
Nov 3, 2021 thin film drug delivery systems and the managing director of Vektor Pharma TF GmbH, a 100% XPhyto owned German drug manufacturer, developer, and research …See details»
XPhyto Signs Transformative Acquisition Agreement With 3a …
Jul 20, 2021 The acquisition facilitates XPhyto's aggressive expansion into the point-of-care biosensor market which is growing at 8% per annum and expected to reach a market size of …See details»
Why XPhyto's PCR Test Kit Is a Game Changer for COVID-19 Testing
Dec 17, 2020 XPhyto Therapeutics Corp. (XPHY:CSE; XPHYF:OTCQB; 4XT:FSE) is a Canadian life sciences company that has just announced highly successful trial results for its …See details»
XPhyto adds Top-Level Executive Talent to its Global Operations
Apr 20, 2021 XPhyto Therapeutics Corp.: Hugh Rogers, CEO and Director Investor Inquiries: Mr. Knox Henderson T: 604-551-2360 E: [email protected] Media Inquiries: MC Services AG …See details»
XPhyto Completes Corporate Rebranding and Launches New …
Mar 4, 2021 VANCOUVER, BC / ACCESSWIRE / March 4, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company"), is pleased to …See details»
XPhyto Reports Development Update for its Drug Delivery …
Oct 12, 2021 XPhyto’s drug formulation business is carried out primarily by its 100% owned, German subsidiary, Vektor Pharma TF GmbH (“Vektor”). Vektor is a German drug …See details»